Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Pre-Market Time (ET) Pre-Market Price Pre-Market Share Volume
06:45:28 $3.69 10
06:32:36 $4.45 900
06:32:36 $4.45 100
06:28:54 $4.40 759
It would certainly be a cleaner sale T39, when it's fully demerged.
I don't really think the management teams heart is in taking Stem all the way to launch, they've got too much other stuff on their plate. Just the best way of protecting the rest of the business and flushing out a buyer/buyers.
$57million of specialist Pharma Investment says this is only the beginning. Good luck all!
Not sure about a Morning Bounce, this is more an Afternoon Delight!
https://www.youtube.com/watch?v=MAhCpAS2AwA
Just the one MM left on 170...
Thunder
Only from memory but didn't the Good Doctor state that all the protocols are in place and just waiting for an export licence of Foralumab from US to Brazil?
FFF - RNS was 17th Sept and Brazil trials due to start in "a few weeks"
A few weeks? More than 2 and less than 4 in my book so imminently and hope for an RNS to confirm
As the Clinical Study for Nasally administered Foralumab is about to start I wanted to document the Covid related patents Tiziana have. Anything I’ve omitted or misunderstood?
24th August (TZLS-501)
Patent granted for methods and use of Anti-IL-6 and IL-6 Monoclonal Anitbodies for Covid 19 and other Pulmonary Diseases e.g. ARDS
• Direct inhalation delivery of TZLS-501 or any other Anti-IL-6/IL6 mAb to the lungs using a hand-held nebulizer
31st July (Foralumab)
Patent submitted for Nasal administration of Foralumab, Anti-CD3 mAb, for treatment of Covid 19 either alone or in combination with other antiviral drugs.
• Related to imminent trial of Foralumab and Dexamethosone in treatment of Covid 19 about to start in Brazil
19th June (Foralumab)
Patent granted for Oral delivery of all Anti-CD3 mAb for treatment of Human Diseases
• First-ever granted patent on oral administration of anti-CD3 monoclonal antibodies for immunotherapies
• Covers oral and nasal administration of all Anti-CD3 mAb
• Covers Covid 19 treatment and any other Human Disease
• Technology can be used on non CD3 antibodies but not covered by patent
FYI - The President has also recently been given Gilead's Remdesivir which has been mentioned via RNS here
https://www.londonstockexchange.com/news-article/TILS/result-of-gm/14707552
https://twitter.com/AshfordPlumber/status/1311972899583070210
Not me BTW
Demerger is done deal according to Twitter. Onwards and upwards folks!
Nice to see some more confirmation of Phase 2 MS trials. I don't believe we had previously been informed:
"Protocol for Phase 2 nasal clinical trial is finalized. The briefing package and protocol was submitted to FDA on July 22, 2020 requesting type C meeting and FDA response expected by mid October, 2020"
Volume is nothing to write home about but the colour is right over in the US.
Will be interested to hear about any short positions today when things close. Cheers
Shiraz - less than a month as you say but what about this Friday being a catalyst to move up? Still technically not a done deal until the vote but with the way the shares are distributed we all know it's going to be approved.
I feel there's people sitting on the sidelines pushing their entry as long as they can and kudos if it works because they're braver than me. Easily possible to miss out on these prices for a few extra days trading
Another trial starting for mAb treatment for Covid 19. This is GlaxoSmithKline but they aren't expecting results until the 2nd half of 2021
https://www.dailymail.co.uk/news/article-8779203/Manchester-man-receive-experimental-arthritis-drug-trial-treat-Covid-19.html
They did issue shares to the Scientific Advisory Board at 128p instead of cash fees.
Ended up being another target for them to aim down to. Maybe now we can move up?
Is there much involved in changing the US ticker?
TZLS is going free
Chris Whitty mentioned Dexamethasone during his press conference. Our Brazil trial will be using Foralumab on it's own and combination with Dexamethasone. Let's hope our Scientists are onto something!